510(k) K974721
K974721 is an FDA 510(k) premarket notification submitted by Bayer Corp. for the device "UNCONJUGATED ESTRIOL ASSAY FOR THE BAYER IMMUNO 1 SYSTEM (IN VITRO DIAGNOSTIC SYSTEM)". The FDA issued a decision of Substantially Equivalent on March 3, 1998. The device falls under product code CGI (Radioimmunoassay, Estriol), a Class I device regulated under 21 CFR 862.1265. Bayer Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 3, 1998
- Date Received
- December 18, 1997
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Estriol
- Device Class
- Class I
- Regulation Number
- 862.1265
- Review Panel
- CH
- Submission Type